Search

Your search keyword '"Spuls, P. I."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Spuls, P. I." Remove constraint Author: "Spuls, P. I." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
36 results on '"Spuls, P. I."'

Search Results

1. Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groups

2. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e‐Delphi process and consensus meeting*

3. Clinical relevance and uptake of core outcome sets in dermatology

5. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

6. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

8. Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

9. Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update

10. Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus Statement

12. Expanding the molecular and clinical spectrum of autosomal recessive congenital ichthyosis caused by pathogenic variants in NIPAL4 and PNPLA1 and evaluation of novel therapeutic interventions

13. Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.

14. Phototherapy for atopic dermatitis: A survey of European practice.

15. The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry

16. Measurement instruments for the core outcome set of congenital melanocytic naevi and an assessment of the measurement properties according to COSMIN:a systematic review

17. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema (TREAT) Registry Taskforce

18. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema (TREAT) Registry Taskforce

20. Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases

21. Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)

22. Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types

25. Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.

26. Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative

27. The HOME Core outcome set for clinical trials of atopic dermatitis.

28. Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals

29. Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis

30. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

31. Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes

32. Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique

33. Clinical characteristics associated with pain in patients with peripheral vascular malformations.

34. The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use.

35. Measurement instruments for the core outcome set of congenital melanocytic naevi and an assessment of the measurement properties according to COSMIN: a systematic review.

36. Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics.

Catalog

Books, media, physical & digital resources